Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled trial evaluated the safety and efficacy of KRP-104 added to metformin in adults with Type 2 diabetes inad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• KRP-104

Snippet

Sponsor: ActivX Biosciences, Inc. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED